Sjögren’s Syndrome Market Size, Share and Forecast to 2026
Sjögren’s Syndrome Market is expected to grow at XX% CAGR during the forecast period 2019-2026
(EMAILWIRE.COM, September 09, 2019 ) Market Overview:
Sjögren’s syndrome (SS) is a chronic, autoimmune, systemic, inflammatory disorder of unknown cause.
It is characterized by dryness of the mouth, eyes, and other mucous membranes due to lymphocytic infiltration of exocrine glands and secondary gland dysfunction.
Market Dynamics:
Factors driving the market include the growing patient population of diseases that can cause SS such as lupus and rheumatoid arthritis. However, the lack of a cure for Sjögren’s syndrome will impact market growth.
Market Segmentation:
By Drug Class
• Cholinergic Agonists
• Off-Label Drugs
By Type
• Primary Sjogren’s Syndrome
• Secondary Sjogren’s Syndrome
By Distribution Channel
• Hospitals
• Retail Pharmacy
• Online Pharmacy
Geographical Analysis:
Geographically, the market is segmented into:
• North America
• South America
• Europe
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Novartis AG
• Allergan Inc.
• Otsuka Pharmaceutical Co., Ltd.
• Santen Pharmaceutical Co., Ltd.
• Nicox S.A.
• Others
View full report: https://www.datamintelligence.com/research-report/sjogrens-syndrome-market
Download free sample: https://www.datamintelligence.com/download-sample/sjogrens-syndrome-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Sjögren’s syndrome (SS) is a chronic, autoimmune, systemic, inflammatory disorder of unknown cause.
It is characterized by dryness of the mouth, eyes, and other mucous membranes due to lymphocytic infiltration of exocrine glands and secondary gland dysfunction.
Market Dynamics:
Factors driving the market include the growing patient population of diseases that can cause SS such as lupus and rheumatoid arthritis. However, the lack of a cure for Sjögren’s syndrome will impact market growth.
Market Segmentation:
By Drug Class
• Cholinergic Agonists
• Off-Label Drugs
By Type
• Primary Sjogren’s Syndrome
• Secondary Sjogren’s Syndrome
By Distribution Channel
• Hospitals
• Retail Pharmacy
• Online Pharmacy
Geographical Analysis:
Geographically, the market is segmented into:
• North America
• South America
• Europe
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Novartis AG
• Allergan Inc.
• Otsuka Pharmaceutical Co., Ltd.
• Santen Pharmaceutical Co., Ltd.
• Nicox S.A.
• Others
View full report: https://www.datamintelligence.com/research-report/sjogrens-syndrome-market
Download free sample: https://www.datamintelligence.com/download-sample/sjogrens-syndrome-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results